Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06074549

DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System

Sponsor: Elixir Medical Corporation

View on ClinicalTrials.gov

Summary

The goal of this registry is to confirm the safety, and performance of the DynamX Coronary Bioadaptor System in patients with coronary artery disease.

Official title: DynamX Bioadaptor Global Post-Market Registry: Clinical Trial of the Elixir Medical DynamX Coronary Bioadaptor System (Bio-RESTORE)

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

5000

Start Date

2024-03-10

Completion Date

2028-12

Last Updated

2025-08-28

Healthy Volunteers

No

Interventions

DEVICE

DynamX Novolimus-eluting Coronary Bioadaptor System

All patients will receive at least one DynamX Bioadaptor implant in a commercial setting in accordance with the product's Instructions for Use

Locations (17)

University Hospital St. Pölten

Pölten, Austria

Curaçao Medical Center

Willemstad, Curacao

Heartology Cardiovascular Hospital

Jakarta, Indonesia

Jakarta Heart Center

Jakarta, Indonesia

Medistra Hospital

Jakarta, Indonesia

Siloam Hospitals

Jakarta, Indonesia

Centro Cardiologico Monzino

Milan, Italy

Azienda Ospedaliera Universitaria "Federico II"

Naples, Italy

Policlinico Tor Vergata

Rome, Italy

Jordon Hospital

Amman, Jordan

The Specialty Hospital

Amman, Jordan

King Fahad Armed Forces Hospital

Jeddah, Saudi Arabia

Istanbul Medipol Mega University Hospital

Istanbul, Turkey (Türkiye)

Memorial Bahçelievler Hospital

Istanbul, Turkey (Türkiye)

Al Qassimi Hospital

Sharjah city, United Arab Emirates

Tam Duc Heart Hospital

Ho Chi Minh City, Vietnam

Kiến Giang General Hospital

Kiến Giang, Vietnam